^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Klisyri (tirbanibulin ointment)

    i
    Other names: KX-01 topical, KX2-391 topical, KX01 topical, ALM-14789, ALM14789
    Associations

    News

    Trials
    Company:
    Almirall, Athenex, Guangzhou Xiangxue Pharma, PharmaEssentia
    Drug class:
    Src kinase inhibitor
    Related drugs:
    Associations

    News

    Trials
    19d
    TIRBACRYO: Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead (clinicaltrials.gov)
    P3, N=59, Not yet recruiting, University Hospital, Lille | Trial completion date: Nov 2027 --> Nov 2028 | Initiation date: Nov 2025 --> Nov 2026 | Trial primary completion date: Nov 2027 --> Nov 2028
    Trial completion date • Trial initiation date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    2ms
    Tirbanibulin for Pediatric Warts (clinicaltrials.gov)
    P4, N=10, Recruiting, The Skin Center Dermatology Group | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Nov 2025 --> Nov 2026
    Trial completion date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    5ms
    TirbAKare: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis (clinicaltrials.gov)
    P3, N=280, Completed, Almirall, S.A. | Trial completion date: Apr 2025 --> Nov 2025
    Trial completion date
    |
    Klisyri (tirbanibulin ointment)
    6ms
    TIRBACRYO: Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead (clinicaltrials.gov)
    P3, N=59, Not yet recruiting, University Hospital, Lille
    New P3 trial
    |
    Klisyri (tirbanibulin ointment)
    11ms
    TirbAKare: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis (clinicaltrials.gov)
    P3, N=280, Completed, Almirall, S.A. | Active, not recruiting --> Completed | Trial completion date: Nov 2026 --> Apr 2025 | Trial primary completion date: Apr 2026 --> Apr 2025
    Trial completion • Trial completion date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    1year
    Tirbanibulin for Pediatric Warts (clinicaltrials.gov)
    P4, N=10, Recruiting, The Skin Center Dermatology Group | Not yet recruiting --> Recruiting
    Enrollment open
    |
    Klisyri (tirbanibulin ointment)
    over1year
    TirbAKare: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis (clinicaltrials.gov)
    P3, N=280, Active, not recruiting, Almirall, S.A. | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    Klisyri (tirbanibulin ointment)
    over1year
    A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp (clinicaltrials.gov)
    P4, N=447, Active, not recruiting, Almirall, S.A. | Recruiting --> Active, not recruiting | Trial completion date: Mar 2027 --> Jul 2027 | Trial primary completion date: Mar 2027 --> Jul 2027
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    over1year
    TirbAKare: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis (clinicaltrials.gov)
    P3, N=270, Recruiting, Almirall, S.A. | Trial completion date: Dec 2024 --> Nov 2026 | Trial primary completion date: Dec 2024 --> Apr 2026
    Trial completion date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    over1year
    Tirbanibulin for Pediatric Warts (clinicaltrials.gov)
    P4, N=10, Not yet recruiting, The Skin Center Dermatology Group
    New P4 trial
    |
    Klisyri (tirbanibulin ointment)
    over1year
    TIRBASKIN: A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses (clinicaltrials.gov)
    P4, N=342, Completed, Almirall, S.A. | Trial completion date: Jan 2023 --> Jan 2024 | Trial primary completion date: Jan 2023 --> Jan 2024
    Trial completion date • Trial primary completion date
    |
    Klisyri (tirbanibulin ointment)
    almost2years
    Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults (clinicaltrials.gov)
    P2, N=5, Completed, Austin Institute for Clinical Research | Recruiting --> Completed | N=10 --> 5
    Trial completion • Enrollment change
    |
    Klisyri (tirbanibulin ointment)